Review Article

Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer

Figure 4

Dosimetric assessment with multiple whole-body and SPECT images using a commercialized program. The retention time of each organ is obtained by imaging data with the images and the estimated absorbed doses for the organs and lesions are calculated using the OLINDA program.